-
Company Profile
Regeneron Pharmaceuticals Inc – Company Profile
Regeneron Pharmaceuticals Inc (Regeneron) is engaged in discovering, developing, manufacturing, and marketing medicines for the treatment of serious medical conditions. Its products are focused on helping patients suffering from cancer, allergic and inflammatory diseases, eye diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, hematologic conditions, pain, and rare diseases. It develops products using its Trap and VelociSuite technology platforms, which include VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, and other related technologies. The company operates manufacturing facilities in Rensselaer, New...
Add to Basket -
Product Insights
NewRegeneron Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Regeneron Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Regeneron Pharmaceuticals Inc (Regeneron) is engaged in discovering, developing, manufacturing, and marketing medicines for the treatment of serious medical conditions. Its products are focused on helping patients suffering from cancer, allergic and inflammatory diseases, eye diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, hematologic conditions, pain, and rare diseases. It develops products using its Trap and VelociSuite technology...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – REGN-5668
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry REGN-5668 Drug Details REGN-5668 is under development for the treatment of advanced epithelial ovarian...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – REGN-5459
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry REGN-5459 Drug Details REGN-5459 is under development for the treatment of relapsed or refractory...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – REGN-7075
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry REGN-7075 Drug Details REGN-7075 in combination with Libtayo (cemiplimab) is under development for the treatment...
-
Product Insights
Respiratory Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Respiratory devices facilitate breathing during respiratory failure and other respiratory disease conditions. This category is further segmented into positive airway pressure devices, non-invasive ventilation masks & circuits, humidifiers, oxygen concentrators, oxygen conservers, ventilators, nebulizers, and respiratory device accessories. The respiratory devices pipeline market research report provides comprehensive information about the respiratory devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.